Conquering Cancer Initiative

Message from the Director of the Salk Cancer Center

Everyone knows someone impacted by cancer. One in two men and one in three women will be diagnosed with cancer in their lifetime. Worldwide, cancer rates are expected to increase by as much as 63 percent by 2040.

Current therapies remain insufficient to address the threat. Through innovative biomedical expertise and collaborations, the Salk Cancer Center is working to develop new therapies and cures to enhance the lives of current and future generations.

Salk’s Conquering Cancer Initiative is a scientific and philanthropic initiative to bring together scientists in collaboration to harness new strategies against five deadly cancers: pancreatic, ovarian, lung, brain (glioblastoma) and triple negative breast. Together, Salk researchers will identify cancer’s vulnerabilities and find new methods to attack tumors and leave healthy tissues alone. Our Conquering Cancer Initiative launched in April 2018 and we are pleased to share our Year One Progress report thanks to supporters and collaborators who serve as our valued partners.

We are at a unique and momentous time in cancer research. We invite you to be a part of our Conquering Cancer Initiative.

Reuben Shaw

“The Salk Cancer Center aims to catalyze discovery beyond boundaries, redefining humanity’s fundamental understanding of cancer. We will leverage that new knowledge to develop therapeutics that transform how we treat cancer.”

– Reuben Shaw, PhD, Director of the Cancer Center at the Salk Institute

Salk’s Conquering Cancer Initiative will further empower our world-renowned cancer research team to transform cancer therapy by engaging our community partners in a collective effort to redefine cancer care.